|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3896111A
(en)
|
1973-02-20 |
1975-07-22 |
Research Corp |
Ansa macrolides
|
|
US4151042A
(en)
|
1977-03-31 |
1979-04-24 |
Takeda Chemical Industries, Ltd. |
Method for producing maytansinol and its derivatives
|
|
US4137230A
(en)
|
1977-11-14 |
1979-01-30 |
Takeda Chemical Industries, Ltd. |
Method for the production of maytansinoids
|
|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
FR2413974A1
(fr)
|
1978-01-06 |
1979-08-03 |
David Bernard |
Sechoir pour feuilles imprimees par serigraphie
|
|
US4265814A
(en)
|
1978-03-24 |
1981-05-05 |
Takeda Chemical Industries |
Matansinol 3-n-hexadecanoate
|
|
US4307016A
(en)
|
1978-03-24 |
1981-12-22 |
Takeda Chemical Industries, Ltd. |
Demethyl maytansinoids
|
|
JPS5562090A
(en)
|
1978-10-27 |
1980-05-10 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
US4256746A
(en)
|
1978-11-14 |
1981-03-17 |
Takeda Chemical Industries |
Dechloromaytansinoids, their pharmaceutical compositions and method of use
|
|
JPS55164687A
(en)
|
1979-06-11 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS5566585A
(en)
|
1978-11-14 |
1980-05-20 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS55102583A
(en)
|
1979-01-31 |
1980-08-05 |
Takeda Chem Ind Ltd |
20-acyloxy-20-demethylmaytansinoid compound
|
|
JPS55162791A
(en)
|
1979-06-05 |
1980-12-18 |
Takeda Chem Ind Ltd |
Antibiotic c-15003pnd and its preparation
|
|
JPS55164685A
(en)
|
1979-06-08 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
JPS55164686A
(en)
|
1979-06-11 |
1980-12-22 |
Takeda Chem Ind Ltd |
Novel maytansinoid compound and its preparation
|
|
US4309428A
(en)
|
1979-07-30 |
1982-01-05 |
Takeda Chemical Industries, Ltd. |
Maytansinoids
|
|
JPS5645483A
(en)
|
1979-09-19 |
1981-04-25 |
Takeda Chem Ind Ltd |
C-15003phm and its preparation
|
|
JPS5645485A
(en)
|
1979-09-21 |
1981-04-25 |
Takeda Chem Ind Ltd |
Production of c-15003pnd
|
|
EP0028683A1
(en)
|
1979-09-21 |
1981-05-20 |
Takeda Chemical Industries, Ltd. |
Antibiotic C-15003 PHO and production thereof
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
WO1982001188A1
(en)
|
1980-10-08 |
1982-04-15 |
Takeda Chemical Industries Ltd |
4,5-deoxymaytansinoide compounds and process for preparing same
|
|
US4450254A
(en)
|
1980-11-03 |
1984-05-22 |
Standard Oil Company |
Impact improvement of high nitrile resins
|
|
US4419446A
(en)
|
1980-12-31 |
1983-12-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant DNA process utilizing a papilloma virus DNA as a vector
|
|
US4315929A
(en)
|
1981-01-27 |
1982-02-16 |
The United States Of America As Represented By The Secretary Of Agriculture |
Method of controlling the European corn borer with trewiasine
|
|
US4313946A
(en)
|
1981-01-27 |
1982-02-02 |
The United States Of America As Represented By The Secretary Of Agriculture |
Chemotherapeutically active maytansinoids from Trewia nudiflora
|
|
JPS57192389A
(en)
|
1981-05-20 |
1982-11-26 |
Takeda Chem Ind Ltd |
Novel maytansinoid
|
|
US4596792A
(en)
|
1981-09-04 |
1986-06-24 |
The Regents Of The University Of California |
Safe vaccine for hepatitis containing polymerized serum albumin
|
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
US4601978A
(en)
|
1982-11-24 |
1986-07-22 |
The Regents Of The University Of California |
Mammalian metallothionein promoter system
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
US4599230A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4599231A
(en)
|
1984-03-09 |
1986-07-08 |
Scripps Clinic And Research Foundation |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
US4965199A
(en)
|
1984-04-20 |
1990-10-23 |
Genentech, Inc. |
Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
|
|
US4970198A
(en)
|
1985-10-17 |
1990-11-13 |
American Cyanamid Company |
Antitumor antibiotics (LL-E33288 complex)
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US4601903A
(en)
|
1985-05-01 |
1986-07-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
US5075109A
(en)
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
|
US5811128A
(en)
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5079233A
(en)
|
1987-01-30 |
1992-01-07 |
American Cyanamid Company |
N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2, Inc., Danville, Calif. |
Geänderte antikörper.
|
|
US4849222A
(en)
|
1987-03-24 |
1989-07-18 |
The Procter & Gamble Company |
Mixtures for treating hypercholesterolemia
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4975278A
(en)
|
1988-02-26 |
1990-12-04 |
Bristol-Myers Company |
Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
|
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
US5770701A
(en)
|
1987-10-30 |
1998-06-23 |
American Cyanamid Company |
Process for preparing targeted forms of methyltrithio antitumor agents
|
|
US5606040A
(en)
|
1987-10-30 |
1997-02-25 |
American Cyanamid Company |
Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
|
|
US5053394A
(en)
|
1988-09-21 |
1991-10-01 |
American Cyanamid Company |
Targeted forms of methyltrithio antitumor agents
|
|
JP2670680B2
(ja)
|
1988-02-24 |
1997-10-29 |
株式会社ビーエムジー |
生理活性物質含有ポリ乳酸系微小球およびその製造法
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
JPH01287029A
(ja)
|
1988-05-13 |
1989-11-17 |
Mect Corp |
新規抗ウィルス剤
|
|
DE68925971T2
(de)
|
1988-09-23 |
1996-09-05 |
Cetus Oncology Corp |
Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5750373A
(en)
|
1990-12-03 |
1998-05-12 |
Genentech, Inc. |
Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
AU641673B2
(en)
|
1989-06-29 |
1993-09-30 |
Medarex, Inc. |
Bispecific reagents for aids therapy
|
|
US5690938A
(en)
|
1989-07-07 |
1997-11-25 |
Oravax, Inc. |
Oral immunization with multiple particulate antigen delivery system
|
|
US5518725A
(en)
|
1989-09-25 |
1996-05-21 |
University Of Utah Research Foundation |
Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
CA2026147C
(en)
|
1989-10-25 |
2006-02-07 |
Ravi J. Chari |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5238843A
(en)
|
1989-10-27 |
1993-08-24 |
Genencor International, Inc. |
Method for cleaning a surface on which is bound a glycoside-containing substance
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
ATE139258T1
(de)
|
1990-01-12 |
1996-06-15 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
US5061620A
(en)
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
|
US5268164A
(en)
|
1990-04-23 |
1993-12-07 |
Alkermes, Inc. |
Increasing blood-brain barrier permeability with permeabilizer peptides
|
|
US5112596A
(en)
|
1990-04-23 |
1992-05-12 |
Alkermes, Inc. |
Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability
|
|
US5643577A
(en)
|
1990-04-24 |
1997-07-01 |
The University Of Newcastle Research Associates Limited |
Oral vaccine comprising antigen surface-associated with red blood cells
|
|
CZ288492B6
(en)
|
1990-04-24 |
2001-06-13 |
Biota Scient Management |
Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
DE69132709T2
(de)
|
1990-06-29 |
2002-06-20 |
Large Scale Biology Corp., Vacaville |
Melaninproduktion durch transformierte mikroorganismen
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
AU8507191A
(en)
|
1990-08-29 |
1992-03-30 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5714374A
(en)
|
1990-09-12 |
1998-02-03 |
Rutgers University |
Chimeric rhinoviruses
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
WO1992006691A1
(en)
|
1990-10-19 |
1992-04-30 |
Biota Scientific Management Pty. Ltd. |
Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
|
|
US5264365A
(en)
|
1990-11-09 |
1993-11-23 |
Board Of Regents, The University Of Texas System |
Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
|
|
US5508192A
(en)
|
1990-11-09 |
1996-04-16 |
Board Of Regents, The University Of Texas System |
Bacterial host strains for producing proteolytically sensitive polypeptides
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
|
DE69222303T2
(de)
|
1991-04-30 |
1998-01-22 |
Eukarion Inc |
Kationisierte antikörper gegen intrazelluläre eiweisse
|
|
DK0590058T3
(da)
|
1991-06-14 |
2004-03-29 |
Genentech Inc |
Humaniseret heregulin-antistof
|
|
GB9114948D0
(en)
|
1991-07-11 |
1991-08-28 |
Pfizer Ltd |
Process for preparing sertraline intermediates
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
WO1993006217A1
(en)
|
1991-09-19 |
1993-04-01 |
Genentech, Inc. |
EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES
|
|
EP0605522B1
(en)
|
1991-09-23 |
1999-06-23 |
Medical Research Council |
Methods for the production of humanized antibodies
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
US5362852A
(en)
|
1991-09-27 |
1994-11-08 |
Pfizer Inc. |
Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
|
|
FI941572A7
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenete lmä
|
|
US5288502A
(en)
|
1991-10-16 |
1994-02-22 |
The University Of Texas System |
Preparation and uses of multi-phase microspheres
|
|
WO1993008829A1
(en)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions that mediate killing of hiv-infected cells
|
|
WO1993009764A1
(en)
|
1991-11-19 |
1993-05-27 |
Center For Innovative Technology |
Combined virustatic antimediator (covam) treatment of common colds
|
|
JPH0826057B2
(ja)
|
1992-01-16 |
1996-03-13 |
株式会社ディ・ディ・エス研究所 |
シアル酸オリゴ糖誘導体及び微粒子キャリヤー
|
|
US5667988A
(en)
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
|
ATE295420T1
(de)
|
1992-02-06 |
2005-05-15 |
Chiron Corp |
Marker für krebs und biosynthetisches bindeprotein dafür
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US5326856A
(en)
|
1992-04-09 |
1994-07-05 |
Cytogen Corporation |
Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
|
|
ZA932522B
(en)
|
1992-04-10 |
1993-12-20 |
Res Dev Foundation |
Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
|
|
JP2904647B2
(ja)
|
1992-06-12 |
1999-06-14 |
株式会社蛋白工学研究所 |
５−ブロム−４−クロロインド−３−イル−２−シアル酸の製造方法
|
|
AU687010B2
(en)
|
1992-07-17 |
1998-02-19 |
Dana-Farber Cancer Institute |
Method of intracellular binding of target molecules
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
DE69328430T2
(de)
|
1992-07-27 |
2001-01-25 |
The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer |
Zielgerichte liposome zur blut-hirne schranke
|
|
WO1994004690A1
(en)
|
1992-08-17 |
1994-03-03 |
Genentech, Inc. |
Bispecific immunoadhesins
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
KR100281264B1
(ko)
|
1992-10-22 |
2001-02-01 |
마나배 게이사꾸 |
신규한 스핀고당 지질 및 그의 사용
|
|
US5807722A
(en)
|
1992-10-30 |
1998-09-15 |
Bioengineering Resources, Inc. |
Biological production of acetic acid from waste gases with Clostridium ljungdahlii
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
DK0752248T3
(da)
|
1992-11-13 |
2000-11-13 |
Idec Pharma Corp |
Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
|
US5780588A
(en)
|
1993-01-26 |
1998-07-14 |
Arizona Board Of Regents |
Elucidation and synthesis of selected pentapeptides
|
|
US5374541A
(en)
|
1993-05-04 |
1994-12-20 |
The Scripps Research Institute |
Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
|
|
US20020037517A1
(en)
|
1993-05-28 |
2002-03-28 |
Hutchens T. William |
Methods for sequencing biopolymers
|
|
CA2163345A1
(en)
|
1993-06-16 |
1994-12-22 |
Susan Adrienne Morgan |
Antibodies
|
|
ES2184769T3
(es)
|
1993-10-22 |
2003-04-16 |
Genentech Inc |
Metodos y composiciones para microencapsulacion de antigenos para utilizar como vacunas.
|
|
US5369017A
(en)
|
1994-02-04 |
1994-11-29 |
The Scripps Research Institute |
Process for solid phase glycopeptide synthesis
|
|
DE69506383T2
(de)
|
1994-02-25 |
1999-06-17 |
E.I. Du Pont De Nemours And Co., Wilmington, Del. |
4-n substituierte sialinsäuren und deren sialoside
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
|
US5622701A
(en)
*
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
ATE306930T1
(de)
|
1994-08-12 |
2005-11-15 |
Immunomedics Inc |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
|
US5639635A
(en)
|
1994-11-03 |
1997-06-17 |
Genentech, Inc. |
Process for bacterial production of polypeptides
|
|
JPH10511085A
(ja)
|
1994-12-02 |
1998-10-27 |
カイロン コーポレイション |
二重特異性抗体を用いる免疫応答を促進する方法
|
|
US5663149A
(en)
|
1994-12-13 |
1997-09-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5840523A
(en)
|
1995-03-01 |
1998-11-24 |
Genetech, Inc. |
Methods and compositions for secretion of heterologous polypeptides
|
|
US6673533B1
(en)
|
1995-03-10 |
2004-01-06 |
Meso Scale Technologies, Llc. |
Multi-array multi-specific electrochemiluminescence testing
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
ATE254965T1
(de)
|
1995-04-25 |
2003-12-15 |
Discovery Partners Internation |
Fernprogrammierbare matrizen mit speichern und verwendungen davon
|
|
AU5632296A
(en)
|
1995-04-27 |
1996-11-18 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US5712374A
(en)
|
1995-06-07 |
1998-01-27 |
American Cyanamid Company |
Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
|
|
US5837234A
(en)
|
1995-06-07 |
1998-11-17 |
Cytotherapeutics, Inc. |
Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
|
|
US6265150B1
(en)
|
1995-06-07 |
2001-07-24 |
Becton Dickinson & Company |
Phage antibodies
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
CA2227871A1
(en)
|
1995-07-26 |
1997-02-13 |
Maxim Pharmaceuticals, Inc. |
Mucosal delivery of polynucleotides
|
|
DE19544393A1
(de)
|
1995-11-15 |
1997-05-22 |
Hoechst Schering Agrevo Gmbh |
Synergistische herbizide Mischungen
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
US6027888A
(en)
|
1996-04-05 |
2000-02-22 |
Board Of Regents, The University Of Texas System |
Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
|
US6340702B1
(en)
|
1996-07-22 |
2002-01-22 |
Sankyo Company, Limited |
Neuraminic acid derivatives, their preparation and their medical use
|
|
US6506564B1
(en)
|
1996-07-29 |
2003-01-14 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
|
TR199901081T2
(xx)
|
1996-11-14 |
1999-08-23 |
Biota Scientific Management Pty.Ltd. |
Y�ntem ve bu y�ntemde kullan�lan yeni bile�imler.
|
|
EP2305027B1
(en)
|
1996-12-03 |
2014-07-02 |
Amgen Fremont Inc. |
Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
|
|
TW555562B
(en)
|
1996-12-27 |
2003-10-01 |
Kirin Brewery |
Method for activation of human antigen-presenting cells, activated human antigen-presenting cells and use thereof
|
|
WO1998047915A1
(en)
|
1997-04-18 |
1998-10-29 |
Novartis Ag |
Neoglycoproteins
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US6083715A
(en)
|
1997-06-09 |
2000-07-04 |
Board Of Regents, The University Of Texas System |
Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
|
|
JPH1135593A
(ja)
|
1997-07-18 |
1999-02-09 |
Daikin Ind Ltd |
２−フルオロフコシル−ｎ−アロイルグルコサミン誘導体及びその中間物、並びにそれらの製造方法
|
|
TW477783B
(en)
|
1997-12-12 |
2002-03-01 |
Gilead Sciences Inc |
Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
EP1064360B1
(en)
|
1998-03-27 |
2008-03-05 |
Prolume, Ltd. |
Luciferases, gfp fluorescent proteins, their nucleic acids and the use thereof in diagnostics
|
|
IL138608A0
(en)
|
1998-04-02 |
2001-10-31 |
Genentech Inc |
Antibody variants and fragments thereof
|
|
PT1071700E
(pt)
|
1998-04-20 |
2010-04-23 |
Glycart Biotechnology Ag |
Modificação por glicosilação de anticorpos para melhorar a citotoxicidade celular dependente de anticorpos
|
|
US6455571B1
(en)
|
1998-04-23 |
2002-09-24 |
Abbott Laboratories |
Inhibitors of neuraminidases
|
|
CN103641885A
(zh)
|
1998-05-06 |
2014-03-19 |
基因技术股份有限公司 |
用离子交换层析纯化蛋白质
|
|
JP3773153B2
(ja)
|
1998-05-29 |
2006-05-10 |
独立行政法人理化学研究所 |
シアル酸誘導体
|
|
US6528286B1
(en)
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
|
GB2342651B
(en)
|
1998-09-18 |
2001-10-17 |
Massachusetts Inst Technology |
Biological applications of semiconductor nanocrystals
|
|
FR2783523B1
(fr)
|
1998-09-21 |
2006-01-20 |
Goemar Lab Sa |
Fuco-oligosaccharides, enzyme pour leur preparation a partir des fucanes, bacterie productrice de l'enzyme et applications des fuco-oligosaccharides a la protection des plantes
|
|
US6696304B1
(en)
|
1999-02-24 |
2004-02-24 |
Luminex Corporation |
Particulate solid phase immobilized protein quantitation
|
|
AUPP913999A0
(en)
|
1999-03-12 |
1999-04-01 |
Biota Scientific Management Pty Ltd |
Novel chemical compounds and their use
|
|
US7090973B1
(en)
|
1999-04-09 |
2006-08-15 |
Oscient Pharmaceuticals Corporation |
Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
|
|
US7854934B2
(en)
|
1999-08-20 |
2010-12-21 |
Sloan-Kettering Institute For Cancer Research |
Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
|
|
US6824780B1
(en)
|
1999-10-29 |
2004-11-30 |
Genentech, Inc. |
Anti-tumor antibody compositions and methods of use
|
|
AUPQ422399A0
(en)
|
1999-11-24 |
1999-12-16 |
University Of New South Wales, The |
Method of screening transformed or transfected cells
|
|
US6727356B1
(en)
|
1999-12-08 |
2004-04-27 |
Epoch Pharmaceuticals, Inc. |
Fluorescent quenching detection reagents and methods
|
|
US20020098513A1
(en)
|
2000-02-17 |
2002-07-25 |
Glycominds Ltd. |
Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
|
|
US7019129B1
(en)
|
2000-05-09 |
2006-03-28 |
Biosearch Technologies, Inc. |
Dark quenchers for donor-acceptor energy transfer
|
|
US7863020B2
(en)
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
|
US6514221B2
(en)
|
2000-07-27 |
2003-02-04 |
Brigham And Women's Hospital, Inc. |
Blood-brain barrier opening
|
|
AU2001286930A1
(en)
|
2000-08-30 |
2002-03-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
AUPR001000A0
(en)
|
2000-09-08 |
2000-10-05 |
Biota Scientific Management Pty Ltd |
Novel chemical compounds and their use
|
|
US7034036B2
(en)
|
2000-10-30 |
2006-04-25 |
Pain Therapeutics, Inc. |
Inhibitors of ABC drug transporters at the blood-brain barrier
|
|
US20030083299A1
(en)
|
2000-11-04 |
2003-05-01 |
Ferguson Ian A. |
Non-invasive delivery of polypeptides through the blood-brain barrier
|
|
JP2002153272A
(ja)
|
2000-11-24 |
2002-05-28 |
Inst Of Physical & Chemical Res |
生体分子マイクロアレイ
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
AU2002338446A1
(en)
|
2001-01-23 |
2002-11-05 |
University Of Rochester Medical Center |
Methods of producing or identifying intrabodies in eukaryotic cells
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
DE10121982B4
(de)
|
2001-05-05 |
2008-01-24 |
Lts Lohmann Therapie-Systeme Ag |
Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung
|
|
EP1434859A2
(en)
|
2001-07-25 |
2004-07-07 |
New York University |
Use of glycosylceramides as adjuvants for vaccines against infections and cancer
|
|
EP1554572B1
(en)
|
2001-07-25 |
2009-10-14 |
Raptor Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
|
HUP0700103A3
(en)
|
2001-08-03 |
2012-09-28 |
Glycart Biotechnology Ag |
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
|
|
DK2322229T3
(en)
|
2001-10-10 |
2017-03-27 |
Novo Nordisk As |
Remodeling and Glycoconjugation of Factor IX
|
|
KR20040077655A
(ko)
|
2001-10-19 |
2004-09-06 |
슈페리어 마이크로파우더스 엘엘씨 |
전자 형상 증착용 테잎 조성물
|
|
AUPR879601A0
(en)
|
2001-11-09 |
2001-12-06 |
Biota Scientific Management Pty Ltd |
Novel chemical compounds and their use
|
|
EP1481356A1
(en)
|
2001-11-21 |
2004-12-01 |
Paradigm Genetics Inc. |
Methods and systems for analyzing complex biological systems
|
|
CN101914158A
(zh)
|
2002-02-14 |
2010-12-15 |
免疫医疗公司 |
抗cd 20抗体及其融合蛋白和使用方法
|
|
US20030162695A1
(en)
|
2002-02-27 |
2003-08-28 |
Schatzberg Alan F. |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
AU2003219277A1
(en)
|
2002-03-14 |
2003-09-29 |
Medical Research Council |
Intracellular antibodies
|
|
DE60328481D1
(de)
|
2002-05-14 |
2009-09-03 |
Novartis Vaccines & Diagnostic |
Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält
|
|
ES2325495T3
(es)
|
2002-07-08 |
2009-09-07 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
Moleculas hibridas de macrolidos con moleculas anti-inflamatorias esteroideas y no esteroideas.
|
|
US20080070324A1
(en)
|
2002-07-15 |
2008-03-20 |
Floyd Alton D |
Quantity control device for microscope slide staining assays
|
|
EP1391213A1
(en)
|
2002-08-21 |
2004-02-25 |
Boehringer Ingelheim International GmbH |
Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents
|
|
US20040062682A1
(en)
|
2002-09-30 |
2004-04-01 |
Rakow Neal Anthony |
Colorimetric sensor
|
|
CN103709250B
(zh)
|
2002-10-17 |
2016-08-10 |
根马布股份公司 |
抗cd20的人单克隆抗体
|
|
KR101111477B1
(ko)
|
2002-12-03 |
2012-02-23 |
블랜체트 록펠러 뉴로사이언시즈 인스티튜트 |
치료제와 연결된 콜레스테롤을 포함하는 접합체
|
|
EP1944320A1
(en)
|
2002-12-16 |
2008-07-16 |
Genentech, Inc. |
Immunoglobulin variants and uses thereof
|
|
CA2512729C
(en)
|
2003-01-09 |
2014-09-16 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
AR044388A1
(es)
|
2003-05-20 |
2005-09-07 |
Applied Molecular Evolution |
Moleculas de union a cd20
|
|
US20040259142A1
(en)
|
2003-06-04 |
2004-12-23 |
Imperial College Innovations Limited |
Products and methods
|
|
WO2005005601A2
(en)
|
2003-06-09 |
2005-01-20 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
JP4148844B2
(ja)
|
2003-06-11 |
2008-09-10 |
ソニー・エリクソン・モバイルコミュニケーションズ株式会社 |
情報端末装置及び音声付画像ファイルの出力方法
|
|
US20050089473A1
(en)
|
2003-09-10 |
2005-04-28 |
Cedars-Sinai Medical Center |
Potassium channel mediated delivery of agents through the blood-brain barrier
|
|
CA2539151A1
(en)
|
2003-09-15 |
2005-03-31 |
Eric Wickstrom |
Implants with attached silylated therapeutic agents
|
|
AU2004275770A1
(en)
|
2003-09-22 |
2005-04-07 |
Acidophil Llc |
Small molecule compositions and methods for increasing drug efficiency using compositions thereof
|
|
US7019288B2
(en)
|
2003-09-30 |
2006-03-28 |
Sequenom, Inc. |
Methods of making substrates for mass spectrometry analysis and related devices
|
|
US20050221337A1
(en)
|
2003-10-02 |
2005-10-06 |
Massachusetts Institute Of Technology |
Microarrays and microspheres comprising oligosaccharides, complex carbohydrates or glycoproteins
|
|
ME01775B
(me)
|
2003-11-05 |
2011-02-28 |
Glycart Biotechnology Ag |
Cd20 antitijela sa povećanim afinitetom vezivanja za fc receptor i efektornom funkcijom
|
|
KR101438983B1
(ko)
|
2003-11-06 |
2014-09-05 |
시애틀 지네틱스, 인크. |
리간드에 접합될 수 있는 모노메틸발린 화합물
|
|
WO2005050224A2
(en)
|
2003-11-13 |
2005-06-02 |
Epitome Biosystems Inc. |
Small molecule and peptide arrays and uses thereof
|
|
EP1723422A2
(en)
|
2004-03-05 |
2006-11-22 |
The Scripps Research Institute |
High throughput glycan microarrays
|
|
JP5848861B2
(ja)
|
2004-04-20 |
2016-01-27 |
ジェンマブ エー／エスＧｅｎｍａｂ Ａ／Ｓ |
Ｃｄ２０に対するヒトモノクローナル抗体
|
|
ITMI20040928A1
(it)
|
2004-05-07 |
2004-08-07 |
Uni Di Bologna Dipartiment O D |
Procedura per la preparazione di coniugati della doxorubicina con l'albumina umana lattosaminata
|
|
AU2005258281A1
(en)
|
2004-06-24 |
2006-01-05 |
The Scripps Research Institute |
Arrays with cleavable linkers
|
|
KR20150140417A
(ko)
|
2004-07-22 |
2015-12-15 |
제넨테크, 인크. |
Ｈｅｒ２ 항체 조성물
|
|
US8022043B2
(en)
|
2004-08-27 |
2011-09-20 |
Albert Einstein College Of Medicine Of Yeshiva University |
Ceramide derivatives as modulators of immunity and autoimmunity
|
|
WO2006055925A2
(en)
|
2004-11-19 |
2006-05-26 |
Swiss Federal Institute Of Technology |
Microarrays for analyte detection
|
|
WO2006064983A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Korea Research Institute Of Bioscience And Biotechnology |
Monoclonal antibody specific human embryonic stem cell
|
|
US7534434B2
(en)
|
2004-12-28 |
2009-05-19 |
The Rockefeller University |
Glycolipids and analogues thereof as antigens for NK T cells
|
|
US7923013B2
(en)
|
2004-12-28 |
2011-04-12 |
The Rockefeller University |
Glycolipids and analogues thereof as antigens for NKT cells
|
|
AU2006231784B2
(en)
|
2005-03-31 |
2010-10-14 |
Biomedics Inc. |
Anti-CD-20 monoclonal antibody
|
|
CN101273063A
(zh)
|
2005-05-24 |
2008-09-24 |
阿维斯塔金格兰技术有限公司 |
用于b细胞淋巴瘤治疗的针对cd20的单克隆抗体的生产方法
|
|
WO2006130458A2
(en)
|
2005-06-02 |
2006-12-07 |
Astrazeneca Ab |
Antibodies directed to cd20 and uses thereof
|
|
US7781203B2
(en)
|
2005-12-29 |
2010-08-24 |
Corning Incorporated |
Supports for assaying analytes and methods of making and using thereof
|
|
EP2001358B1
(en)
|
2006-03-27 |
2016-07-13 |
University Of Maryland, Baltimore |
Glycoprotein synthesis and remodeling by enzymatic transglycosylation
|
|
ATE467836T1
(de)
|
2006-05-18 |
2010-05-15 |
Veterinaermedizinische Uni Wie |
Nachweisverfahren für grippeviren
|
|
WO2007146847A2
(en)
|
2006-06-09 |
2007-12-21 |
University Of Maryland, Baltimore |
Glycosylation engineered antibody therapy
|
|
JP5215298B2
(ja)
|
2006-07-12 |
2013-06-19 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グリコシル化された基質から切断される末端単糖の固相検出
|
|
EP2059593A2
(en)
|
2006-08-18 |
2009-05-20 |
Oncotherapy Science, Inc. |
Treating or preventing cancers over-expressing reg4 or kiaa0101
|
|
WO2008067283A2
(en)
|
2006-11-27 |
2008-06-05 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
|
CA2676323A1
(en)
|
2007-01-18 |
2008-07-24 |
Suomen Punainen Risti, Veripalvelu |
Novel methods and reagents directed to production of cells
|
|
CA2712562A1
(en)
|
2007-01-18 |
2008-07-24 |
Glykos Finland Ltd |
Novel specific cell binders
|
|
CA2680415A1
(en)
|
2007-03-07 |
2008-09-12 |
Daiichi Sankyo Company, Limited |
Neuraminic acid derivatives useful in the treatment of influenza
|
|
US20080220988A1
(en)
|
2007-03-07 |
2008-09-11 |
Ada Technologies, Inc. |
Preparing carbohydrate microarrays and conjugated nanoparticles
|
|
US7943330B2
(en)
|
2007-03-23 |
2011-05-17 |
Academia Sinica |
Tailored glycoproteomic methods for the sequencing, mapping and identification of cellular glycoproteins
|
|
DK2308514T3
(da)
|
2007-03-23 |
2013-09-02 |
To Bbb Holding B V |
Konjugater til målrettet lægemiddeltransport gennem blod-hjerne barrieren
|
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
|
WO2008128207A1
(en)
|
2007-04-13 |
2008-10-23 |
Academia Sinica |
Alpha-galactosyl ceramide analogs and their use as immunotherapies
|
|
CA2685015A1
(en)
|
2007-04-23 |
2008-11-06 |
Schering Corporation |
Anti-mdl-1 antibodies
|
|
EP2187217B1
(en)
|
2007-08-24 |
2013-11-06 |
Lsip, Llc |
Detection method of gynecologic cancer
|
|
EP2190439B1
(en)
|
2007-08-31 |
2016-03-09 |
Academia Sinica |
Oseltamivir phosphonate derivatives with anti-influenza activity and synthesis thereof
|
|
FR2921387B1
(fr)
|
2007-09-26 |
2012-04-20 |
Sanofi Pasteur |
Procede de production du virus de la grippe
|
|
US8647626B2
(en)
|
2007-10-02 |
2014-02-11 |
Avaxia Biologics, Incorporated |
Compositions comprising TNF-specific antibodies for oral delivery
|
|
US20090123439A1
(en)
|
2007-11-09 |
2009-05-14 |
The Jackson Laboratory |
Diagnostic and prognosis methods for cancer stem cells
|
|
CA2710779C
(en)
|
2007-12-31 |
2017-06-20 |
Bayer Schering Pharma Aktiengesellschaft |
Antibodies to tnf.alpha.
|
|
MY152105A
(en)
|
2008-03-21 |
2014-08-15 |
Danisco Us Inc |
Hemicellulase enriched compositions for enhancing hydrolysis of biomass
|
|
US8551959B2
(en)
|
2008-03-25 |
2013-10-08 |
Riken |
Glycolipid and use thereof
|
|
US8383554B2
(en)
|
2008-04-14 |
2013-02-26 |
Academia Sinica |
Quantitative microarray of intact glycolipid CD1d interaction and correlation with cell-based cytokine production
|
|
US8906832B2
(en)
|
2008-04-30 |
2014-12-09 |
Academia Sinica |
Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants
|
|
CN102036658A
(zh)
|
2008-05-23 |
2011-04-27 |
香港大学 |
治疗流感的联合疗法
|
|
US20110137570A1
(en)
|
2008-05-30 |
2011-06-09 |
Anthony Lapadula |
Methods for structural analysis of glycans
|
|
CN102065868A
(zh)
|
2008-06-16 |
2011-05-18 |
中央研究院 |
诱发对于Globo H及SSEA3的特异免疫反应的组合物以及其在癌症治疗中的用途
|
|
CA2728574C
(en)
|
2008-06-16 |
2020-10-20 |
Academia Sinica |
Cancer diagnosis based on levels of antibodies against globo h and its fragments
|
|
JP2010014691A
(ja)
|
2008-06-20 |
2010-01-21 |
Igaku Seibutsugaku Kenkyusho:Kk |
腹水中のメソテリン及び／又は巨核球増強因子を検出するための方法、キット、試薬及び装置
|
|
US7928077B2
(en)
|
2008-07-11 |
2011-04-19 |
Academia Sinica |
Alpha-galactosyl ceramide analogs and their use as immunotherapies
|
|
JP5986745B2
(ja)
|
2008-07-15 |
2016-09-06 |
アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ |
Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
|
|
US20100022916A1
(en)
|
2008-07-24 |
2010-01-28 |
Javanbakhsh Esfandiari |
Method and Apparatus for Collecting and Preparing Biological Samples for Testing
|
|
ES2555220T3
(es)
|
2009-03-27 |
2015-12-29 |
Academia Sinica |
Donantes de sialil-fosfato selectivos para la preparación de sialósidos y matrices de sialósidos para la detección del virus de la gripe
|
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
|
CN102471361B
(zh)
|
2009-07-15 |
2016-06-01 |
不列颠哥伦比亚大学 |
作为神经氨酸酶抑制剂的2,3-氟化糖苷及其作为抗病毒药物的用途
|
|
WO2011011474A1
(en)
|
2009-07-22 |
2011-01-27 |
Enzon Pharmaceuticals, Inc. |
Methods of treating her2 positive cancer with her2 receptor antagonist in combination with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
|
|
WO2011031236A1
(en)
|
2009-09-14 |
2011-03-17 |
Thailand Excellence Center For Tissue Engineering |
Phytochemical compositions including xanthones for anti-inflammatory, anti-cytokine storm, and other uses
|
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
|
JPWO2011074621A1
(ja)
|
2009-12-18 |
2013-04-25 |
株式会社医学生物学研究所 |
メソセリン（ｍｓｌｎ）に対する抗体及びその用途
|
|
EP2347769A1
(en)
|
2010-01-20 |
2011-07-27 |
Glycotope GmbH |
Cancer stem cell markers and uses thereof
|
|
NZ601580A
(en)
|
2010-02-11 |
2014-11-28 |
Alexion Pharma Inc |
Therapeutic methods using anti-cd200 antibodies
|
|
EP3620467A1
(en)
|
2010-03-12 |
2020-03-11 |
Debiopharm International SA |
Cd37-binding molecules and immunoconjugates thereof
|
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
|
EP3072961A1
(en)
|
2010-04-16 |
2016-09-28 |
Children's Medical Center Corporation |
Sustained polypeptide expression from synthetic, modified rnas and uses thereof
|
|
CA2835489C
(en)
|
2010-05-10 |
2018-03-06 |
Chi-Huey Wong |
Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
|
|
WO2011145957A1
(en)
|
2010-05-20 |
2011-11-24 |
Auckland Uniservices Limited |
Agents and methods for detection and/or imaging of hypoxia
|
|
RU2604811C2
(ru)
|
2010-05-27 |
2016-12-10 |
Мерк Шарп Энд Домэ Корп. |
Способ получения антител с улучшенными свойствами
|
|
GB201015569D0
(en)
|
2010-09-16 |
2010-10-27 |
Medical Res Council |
Blood assay for prions
|
|
WO2012082635A1
(en)
|
2010-12-13 |
2012-06-21 |
Ancora Pharmaceuticals, Inc. |
Synthetic oligosaccharide group a streptococcus
|
|
CA2854725C
(en)
|
2011-01-05 |
2019-10-22 |
National Taiwan University |
Methods for preparation of glycosphingolipids and uses thereof
|
|
US10851174B2
(en)
|
2011-03-03 |
2020-12-01 |
University Of Maryland, Baltimore |
Core fucosylated glycopeptides and glycoproteins: chemoenzymatic synthesis and uses thereof
|
|
CA2834589A1
(en)
|
2011-05-25 |
2012-11-29 |
Merck Sharp & Dohme Corp. |
Method for preparing fc-containing polypeptides having improved properties
|
|
EP3418300B1
(en)
|
2011-07-18 |
2020-10-28 |
Institute for Research in Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
|
AU2012295802B2
(en)
|
2011-08-12 |
2017-03-30 |
Nissan Chemical Industries, Ltd. |
Tricyclic heterocyclic compounds and JAK inhibitors
|
|
WO2013074598A1
(en)
|
2011-11-18 |
2013-05-23 |
Merck Sharp & Dohme Corp. |
Fc CONTAINING POLYPEPTIDES HAVING INCREASED ANTI-INFLAMMATORY PROPERTIES AND INCREASED FcRN BINDING
|
|
EP2604281B1
(en)
|
2011-12-14 |
2014-07-30 |
Centre National de la Recherche Scientifique (CNRS) |
Clicked somatostatin conjugated analogs for biological applications
|
|
EP2812442B9
(en)
|
2012-02-10 |
2023-02-15 |
University of Maryland, Baltimore |
Chemoenzymatic glycoengineering of antibodies and fc fragments thereof
|
|
US9846160B2
(en)
*
|
2012-02-27 |
2017-12-19 |
Board Of Regents, The University Of Texas Systems |
Ganglioside GD2 as a marker and target on cancer stem cells
|
|
HK1207000A1
(en)
*
|
2012-04-02 |
2016-01-22 |
Merrimack Pharmaceuticals, Inc. |
Dosage and administration of monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
|
|
WO2013151649A1
(en)
|
2012-04-04 |
2013-10-10 |
Sialix Inc |
Glycan-interacting compounds
|
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
|
US20150158943A1
(en)
|
2012-06-01 |
2015-06-11 |
Momenta Pharmaceuticals, Inc. |
Methods related to adalimumab
|
|
US9914956B2
(en)
|
2012-08-18 |
2018-03-13 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
|
TWI567200B
(zh)
|
2012-08-20 |
2017-01-21 |
中央研究院 |
寡醣之大規模酵素合成
|
|
CA2883168A1
(en)
|
2012-08-21 |
2014-02-27 |
Academia Sinica |
Benzocyclooctyne compounds and uses thereof
|
|
JP6559066B2
(ja)
|
2012-10-30 |
2019-08-14 |
エスペランス ファーマシューティカルズ， インコーポレイテッド |
抗体／薬剤結合体及び使用方法
|
|
WO2014078373A1
(en)
|
2012-11-13 |
2014-05-22 |
Iogenetics, Llc |
Antimicrobial compositions
|
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
|
WO2014210564A1
(en)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Glycan conjugates and use thereof
|
|
TWI599370B
(zh)
|
2013-07-26 |
2017-09-21 |
中央研究院 |
靈芝多醣誘發之抗體介導抗腫瘤活性
|
|
KR102298172B1
(ko)
|
2013-09-06 |
2021-09-06 |
아카데미아 시니카 |
변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화
|
|
CA2922958A1
(en)
|
2013-09-12 |
2015-03-19 |
Teva Pharmaceutical Industries Ltd. |
Gene expression biomarkers of laquinimod responsiveness
|
|
WO2015054039A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO FcGammaRIIB
|
|
US10150818B2
(en)
*
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
CA2937123A1
(en)
|
2014-01-16 |
2015-07-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
TWI797430B
(zh)
|
2014-03-27 |
2023-04-01 |
中央研究院 |
反應性標記化合物及其用途
|
|
AU2015267045B2
(en)
|
2014-05-27 |
2021-02-25 |
Academia Sinica |
Anti-HER2 glycoantibodies and uses thereof
|
|
FI3149045T3
(fi)
|
2014-05-27 |
2023-03-20 |
Academia Sinica |
Koostumuksia ja menetelmiä, jotka liittyvät yleisglykoformeihin vasta-aineiden parannettua tehokkuutta varten
|
|
US20150344585A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
|
US10118969B2
(en)
*
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
|
US11332523B2
(en)
|
2014-05-28 |
2022-05-17 |
Academia Sinica |
Anti-TNF-alpha glycoantibodies and uses thereof
|
|
NZ729243A
(en)
|
2014-08-22 |
2018-08-31 |
Academia Sinica |
Novel glycan conjugates and use thereof
|
|
TWI745275B
(zh)
|
2014-09-08 |
2021-11-11 |
中央研究院 |
使用醣脂激活人類ｉＮＫＴ細胞
|
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
WO2016118090A1
(en)
|
2015-01-23 |
2016-07-28 |
Agency For Science, Technology And Research |
Cancer specific antigen-binding proteins
|
|
US20170283878A1
(en)
|
2015-12-11 |
2017-10-05 |
Academia Sinica |
Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers
|
|
US11041017B2
(en)
*
|
2016-03-29 |
2021-06-22 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
|
TWI764917B
(zh)
*
|
2016-08-22 |
2022-05-21 |
醣基生醫股份有限公司 |
抗體、結合片段及使用方法
|
|
WO2018094414A1
(en)
*
|
2016-11-21 |
2018-05-24 |
Obi Pharma, Inc. |
Conjugated biological molecules, pharmaceutical compositions and methods
|